Drug intelligence / Profile preview

TCM-padia001

Development stage
Unknown
Lead developer
Tianjin Medical University Cancer Institute and Hospital
Administration
Oral
01

Overview

TCM-padia001 is a Traditional Chinese Medicine (TCM) herbal formula developed by the Tianjin Medical University Cancer Institute and Hospital for the prevention and treatment of pyrotinib-induced diarrhea. Pyrotinib is an irreversible pan-HER tyrosine kinase inhibitor used to treat HER2-positive metastatic breast cancer, but it is associated with high rates of gastrointestinal toxicity. This oral TCM formula is intended for patients whose diarrhea is refractory to standard antidiarrheal treatments such as loperamide or montmorillonite powder. In a Phase 2 clinical trial (NCT04988165), the formula demonstrated efficacy in reducing the severity of diarrhea and improving the quality of life for breast cancer patients undergoing pyrotinib therapy.

Other names
Traditional Chinese MedicineTCM formula for pyrotinib-associated diarrhea

Beyond the preview

Go deeper on TCM-padia001.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TCM-padia001.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call